Spinal Tech

Bacterin Reports $6M in Q1 Revenue, 119% Increase

Bacterin, a manufacturer of bone graft material and antimicrobial coatings for medical applications, has posted revenues of $6 million for the first quarter 2011, an increase of 119 percent compared to the same quarter last year, according to a company news release.

Jaimie Oh

Tuesday, May 17th, 2011

The company’s continued growth in revenue can be attributed to product penetration and continued expansion of a direct sales force. Bacterin expects to see continued revenue growth acceleration with its expanded sales force and two recently launched biologics scaffolds: Osteosponge SC and hMatrix.

Read the company news release about Bacterin’s first quarter financial results.

Related Articles on Device Company Financial Results:
SANUWAVE Posts Q1 $252K Revenue, 76% Increase
TranS1 Reports $5.1M in Q1 Revenues, 24% Decrease
DJO Global Reports $249.7M in Q1 Net Sales

Next Up in Spinal Tech

Where AI 'actually makes a difference' in spine care: Dr. David Skaggs

AI in spine care has been commonly leveraged to support administrative tasks, but one of its real potentials lies in…

By: Carly Behm
Wednesday, November 19th, 2025
Stryker net sales up 10.3% in Q3: 5 notes

Medtech company Stryker reported sales increases across multiple portfolios in the third quarter, according to financial results posted Oct. 30.…

By: Ariana Portalatin
Friday, October 31st, 2025
4 spine FDA nods in October

Here are four companies earning FDA clearance for spine technology this month: 1. Elevation Spine’s Saber-C earned FDA clearance for…

By: Ariana Portalatin
Friday, October 31st, 2025

Comments are closed.

From claims chaos to clean: How top practices are fixing RCM friction

Next Up in Spinal Tech

Where AI 'actually makes a difference' in spine care: Dr. David Skaggs

Stryker net sales up 10.3% in Q3: 5 notes

4 spine FDA nods in October

Join the spine leaders & surgeons who start their day with Becker's